Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Companion Animal Veterinary Vaccines Research Report 2026: $5.38 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

April 29, 2026

Farm Animal Drugs Research Report 2026: $28.88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

April 29, 2026

All the evidence unveiled so far in Musk v. Altman

April 29, 2026

Pet Cancer Therapeutics Research Report 2026: $720 Mn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

April 29, 2026

Royal Columbian Hospital Foundation unveils the Jack & Sylvia Gin Emergency & Trauma Imaging Centre (GinETIC)

April 29, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » AB INTL GROUP Announces Launch of a Film Entity as Subsidiary in China
Press Release

AB INTL GROUP Announces Launch of a Film Entity as Subsidiary in China

By News RoomSeptember 4, 20244 Mins Read
AB INTL GROUP Announces Launch of a Film Entity as Subsidiary in China
Share
Facebook Twitter LinkedIn Pinterest Email

NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) — AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, announces the launch of a wholly owned subsidiary in China, which is aiming to tap into one of the world’s largest and most dynamic film markets.

1.Market Access and Revenue Potential: China’s film industry has been rapidly growing, ranking as the second-largest box office market globally. By establishing a subsidiary there, ABQQ gains direct access to this lucrative market without the need for third-party distributors, potentially increasing profit margins.
2. Cultural and Content Localization: Operating directly in China allows ABQQ to better tailor its content to local tastes, which is crucial given China’s stringent content regulations and cultural preferences. This could lead to higher acceptance and box office success for films distributed through their subsidiary.
3. Strategic Partnerships: The collaboration with Hua Xia Film Group for films yearly indicates that ABQQ is not just entering the market but doing so with established partners. This can facilitate smoother regulatory navigation, distribution, and marketing within China, leveraging local expertise.
4. Risk Management: While entering the Chinese market offers significant opportunities, it also comes with risks like regulatory changes, censorship, and market competition. By setting up a subsidiary, ABQQ is looking to manage these risks more effectively, perhaps by localizing operations, understanding, and adapting to the regulatory environment more swiftly.
5. Brand Expansion and Global Strategy: This move could be part of a broader strategy to expand ABQQ’s brand globally. Having a physical presence in key markets like China can enhance ABQQ’s reputation as a global player in film distribution, potentially attracting more international projects or partnerships.
6. Challenges: Despite the potential, ABQQ will face challenges like navigating China’s complex business environment, dealing with intellectual property rights issues, and ensuring content compliance with local laws. The success of a newly release film will be a litmus test for our strategy.
7. Long-term Vision: This could be part of a long-term vision where ABQQ aims to not just distribute films but perhaps produce content specifically for the Chinese market or even expand into other entertainment sectors, given China’s growing digital content consumption.

ABQQ China

“ABQQ’s successful establishment of this film business subsidiary in China reflects ABQQ’s strategic move to capitalize on the growing Chinese market, potentially increase revenue, and establish a stronger global presence in the film industry. We understand that the success of this business depends heavily on capital investment, and I am confident that the team will be able to adapt to local market dynamics, manage risk, and deliver content that resonates with Chinese audiences,” stated Chiyuan Deng, CEO, who also serves as a film director and producer.

About AB International Group Corp.
AB International Group Corp. is an intellectual property (IP) and movie investment and licensing firm, focused on acquisitions and development of various intellectual property. We are engaged in acquisition and distribution of movies. The Company operates AB Cinemas, physical movie theaters currently in NY with plans to expand nationwide (www.abcinemasny.com). The company also owns ABQQ.TV which is a movie and TV show online streaming platform. ABQQ TV generates revenue through a hybrid subscription model and advertising model like other online streaming platforms.

For additional information, visit www.abqqs.com, www.abcinemasny.com, and www.ABQQ.tv.

Forward-Looking Statements
This press release contains “forward-looking statements” that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements relating to changes to the Company’s management team and statements relating to the Company’s transformation, financial and operational performance including the acceleration of revenue and margins, and the Company’s overall strategy. Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the possibility of business disruption, competitive uncertainties, and general economic and business conditions in AB International Group markets as well as the other risks detailed in company filings with the Securities and Exchange Commission. AB International Group undertakes no obligation to update any statements in this press release for changes that happen after the date of this release.

Investor Relations Contact:

Charles Tang
(852) 2622 2891
[email protected]

Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/00b8bdcc-dcdb-4c14-b9c5-fcaf6a315c89

https://www.globenewswire.com/NewsRoom/AttachmentNg/5331fe87-8f9f-4807-9330-8693655dd5cf

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Companion Animal Veterinary Vaccines Research Report 2026: $5.38 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Farm Animal Drugs Research Report 2026: $28.88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Pet Cancer Therapeutics Research Report 2026: $720 Mn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Royal Columbian Hospital Foundation unveils the Jack & Sylvia Gin Emergency & Trauma Imaging Centre (GinETIC)

CoinMafia.io is a Company. $MAFIA is the Coin. The Difference Matters.

Driving Elegance Together — LEPAS Global Partner Conference Successfully Concludes

Anticoccidial Drugs Research Report 2026: $1.84 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

HON Introduces Brim: A Sculpted Polyshell Chair Designed for Comfort and Versatility

Crowdfunder Expands in NYC, Opens Applications for 50 Founding Nonprofits, Introduces Spark Match Funding for Eight Selected Partners

Editors Picks

Farm Animal Drugs Research Report 2026: $28.88 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

April 29, 2026

All the evidence unveiled so far in Musk v. Altman

April 29, 2026

Pet Cancer Therapeutics Research Report 2026: $720 Mn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

April 29, 2026

Royal Columbian Hospital Foundation unveils the Jack & Sylvia Gin Emergency & Trauma Imaging Centre (GinETIC)

April 29, 2026

Latest News

CoinMafia.io is a Company. $MAFIA is the Coin. The Difference Matters.

April 29, 2026

Driving Elegance Together — LEPAS Global Partner Conference Successfully Concludes

April 29, 2026

Anticoccidial Drugs Research Report 2026: $1.84 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

April 29, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version